Renal functional response to vasopressor agents in shock.

G. Morris,J. Moyer,H. Beazley

Abstract:

What problem does this paper attempt to address?

Intrauterine device use is safe among nulligravidas and adolescent girls

M Valeria Bahamondes,Luis Bahamondes

DOI: https://doi.org/10.1111/aogs.14097

Abstract:The use of intrauterine devices (IUDs), including the copper-bearing device and the levonorgestrel intrauterine system (LNG-IUS), is safe among nulligravidas and adolescent girls. However, several misconceptions limit their use in clinical practice; health-care providers are hesitant to prescribe IUDs, and several myths associated with their usage in nulligravidas and adolescents exist among both providers and women themselves. The high rates of unplanned pregnancies (which in many settings constitute a public health issue, primarily among adolescent females) can be attributed at least partially to lack of awareness and limited use of highly effective contraceptives such as IUDs. In this review, we discuss the role of non-hormonal and hormonal IUDs as effective contraceptives in nulligravidas and adolescent girls. We present a literature review of data that highlight contraceptive efficacy, side effects (including reasons for discontinuation), and continuation rates with the method. We searched the PubMed/MEDLINE, Cochrane Library, Embase, and Scopus databases for all articles published in English between January 1990 through September 2020. A large body of evidence confirmed the effectiveness of IUD/IUS, independent of age and parity. Studies showed a high expulsion rate among adolescents but not among nulligravidas. Additionally, bleeding patterns among adolescents and nulligravidas were similar to those observed among adults and parous women. The high early removal rates observed in adolescents were attributable to bleeding and/or pain, which indicate that compared with adults, adolescents are less likely to accept IUD-induced side effects. IUD placement is an excellent strategy to avoid the high rates of unplanned pregnancies in adolescents and nulligravidas. IUDs are more effective than short-acting reversible contraceptives with failure rates that are equivalent to those observed with permanent contraception. However, few long-term studies have investigated this category of women to definitively establish the role of IUD/IUS as effective means of contraception.
188. National Practices and Attitudes Surrounding Intrauterine Devices and Contraceptive Implant Procedures For Adolescents in the Inpatient Setting

Shelby N. Edmondson,Surabhi Madadi,Megan Gribbons,Nirupama DeSilva,Katelyn Jetelina,Susan L. Rosenthal,Jenny K.R. Francis

DOI: https://doi.org/10.1016/j.jadohealth.2023.11.387

IF: 7.898

2024-02-01

Journal of Adolescent Health

Abstract:We aim to describe national practices about placing intrauterine devices (IUDs) and contraceptive implants (implants) for adolescents in the inpatient setting and characterize the attitudes of clinicians about barriers and facilitators of offering these procedures.

pediatrics,public, environmental & occupational health,psychology, developmental
64. Immediate postpartum IUD use among adolescents in the United States: Update from National Inpatient Sample

Margarita Berwick,Xuban Palau Villarreal,Laurel Deaton,Caitlin Rogers

DOI: https://doi.org/10.1016/j.jpag.2024.01.071

IF: 2.046

2024-04-04

Journal of Pediatric and Adolescent Gynecology

Abstract:Background Intrauterine devices (IUDs) are a highly effective method of contraception and are the recommended form of contraception in adolescents. Immediate postpartum IUD placement is associated with lower rates of unintended pregnancy and short interval pregnancy, both of which are prevalent in adolescents. Data regarding immediate postpartum IUD use is not widely available; at the same time, understanding utilization of immediate postpartum IUDs in adolescents is crucial for local, regional, and national resource allocation, safety monitoring, and public health efforts in surveillance of unintended adolescent pregnancy rates. Methods National Inpatient Sample (NIS) data was used. Most recently available data comprised of years 2019 and 2020 were requested. Analyses were conducted using descriptive statistical methods and chi-square. The study was deemed exempt from Institutional Review Board (IRB) review. Results The results of the analysis revealed noteworthy disparities in immediate postpartum IUD usage across various age groups among adolescents and young adults. Specifically, within the adolescent population, aged 12 to 15 years, 2.0 percent received immediate postpartum IUDs in 2019 and 2020. This rate was lower among adolescents aged 16 to 19 years, where 0.7 percent received immediate postpartum IUDs. Furthermore, in the adult age group of 20-24 years, the immediate postpartum IUD usage was found to be 0.6 percent. The differences in immediate postpartum IUD usage across different age groups were found to be statistically significant. With regard to geographic distribution, immediate postpartum IUD use was more common in counties of medium-sized metro areas compared with both large metro areas and small metro or non-metro areas. Conclusions Overall utilization of immediate postpartum IUDs remains low. However, our data analysis highlights that the usage is notably higher among younger adolescents aged 12 to 15 years. Insights into national trends are essential for developing focused strategies to improve access to effective contraception methods among adolescents, helping to reduce unintended pregnancies in this vulnerable population.

pediatrics,obstetrics & gynecology
Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting

K Tocce,J Sheeder,J Python,S B Teal

DOI: https://doi.org/10.1016/j.jpag.2011.09.003

Abstract:Study objective: To evaluate the outpatient initiation of postpartum long-acting reversible contraception (LARC). Design: Prospective cohort study of pregnant adolescents' prenatal contraceptive intentions and successful postpartum initiation of LARC. Setting: Urban, university hospital-affiliated, adolescent outpatient clinic. Participants: Adolescents attending an integrated prenatal and postpartum maternity clinic. Interventions: Data were collected via the electronic medical record and telephone interview. Main outcome measures: Contraceptive intentions during the third trimester, contraceptive methods used postpartum, timing of LARC initiation, timing of resumption of intercourse. Results: 116 patients were enrolled; 75% intended LARC use postpartum. Of 38 implant-intenders, 14 received it within 14 days postpartum. All reported abstinence pre-placement. Mean time to insertion was 18±13 days. Of 37 IUD-intenders, only two received one by 8 weeks postpartum. By 14 weeks postpartum, 43% received one. Over half reported intercourse prior to insertion; the only method of contraception used was condoms. Mean time to insertion was 70±11 days. Resumption of intercourse prior to initiation of the intended LARC method was significantly higher in IUD recipients compared to those who intended and received the implant (RR 8.8; CI 1.3-57.5). Conclusion: In postpartum teens attending a clinic that prioritizes contraceptive use, the implant is far more likely to be received prior to resumption of sexual activity than the IUD. This may be due to more and earlier opportunities for placement, or waning commitment with time since delivery. Post-placental IUDs may be needed to equal the success of the implant in this patient population. Short-acting, reliable contraceptive methods should be implemented for postpartum adolescents preferring to wait for IUD insertion.
Multi Objective Optimization of Cloud Computing Services for Consumers

Eli Weintraub,Yuval Cohen

DOI: https://doi.org/10.14569/IJACSA.2017.080219

Abstract:This paper presents a novel multi objective model for optimizing the purchase decision of a cloud computing services customer. The providers are typically offering consumers cloud computing varying information systems services. The cloud services consist of different functionalities at varying costs, and varying reliability. So the customer’s main objectives (based on the literature) are to maximize their utility, and minimize their costs and risks. Since utility cost and risks are different dimensions, the problem is essentially a multi-objective optimization problem. So far, previous research does not address the multi objective nature of the problem. This article deals with optimizing consumers’ decision, but at the same time maintaining each of their objectives’ considerations. An optimization model presented and illustrated. The article also demonstrates the advantages gained by the optimization model when implemented using the dynamic cloud architecture over the traditional cloud architecture.
[An update in intrauterine contraception]

M Mawet,N Chabbert Buffet,M Gerard,M Nisolle,F Kridelka,A Pintiaux

Abstract:Intrauterine devices (IUD) are the oldest of the modern contraceptives. There are currently two types of IUDs: copper IUD (Cu-IUD) and levonorgestrel IUD (LNG-IUD). Both offer high contraceptive effectiveness. Although they have been used for decades, the literature still brings its share of new information on IUDs: impact on oncological risk, non-contraceptive benefits, rare adverse effects, and impact on women's well-being. In addition, Cu-DIU is recognized as the most effective emergency contraceptive and can be inserted up to 5-7 days after the at-risk sexual intercourse. Research is now looking at the effectiveness of LNG-IUD in emergency contraception. Finally, new IUD concepts are also being evaluated: they should allow a reduction in the rate of expulsion, intermenstrual and heavy menstrual bleeding, an increase in comfort and in IUDs duration of use. This article makes an update on the latest developments in terms of intrauterine contraceptives.
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women

Elaine Cristina Fontes de Oliveira,Janaína Campos Senra,Ana Luiza Lunardi Rocha

DOI: https://doi.org/10.1080/13625187.2024.2379363

2024-08-07

Abstract:Purpose: To evaluate the impact of levonorgestrel-releasing intrauterine device (LNG-IUD) use on the incidence of acne in adolescents and young women. Methods: A narrative review was conducted in PubMed, Embase, Cochrane, and SciELO assessing the incidence of acne in adolescents and young women using LNG-IUD (13.5, or 19.5 mg, or 52 mg). Cohort, cross-sectional studies, clinical trials, and meta-analyses were included, without a date limit. Studies that didn't evaluate women in the age of interest were excluded. Only articles in English were selected. Results: Nine articles were included in this narrative review. Only clinical trials, cohort studies, and cross-sectional studies were evaluated. Two cross-sectional studies evaluated the incidence of acne in women using any contraceptive methods, with the incidence of acne being 36% in women aged 17 to 47 using LNG-IUD in one study. In another study, acne incidence ranged from 2 to 8% in women using any contraceptive methods, with higher rates in younger women and LNG-IUD users. The incidence of acne varies and participants between 16 to 35 years were more likely to report new acne or worsening of pre-existing acne. In a prospective cohort study of women between 16 and 24 years, acne was a common adverse effect, with 44% in the first year. Conclusion: The data indicate variability in the incidence of acne among LNG-IUD users, with a higher prevalence observed in younger women. Further research should focus on the effects of LNG-IUD on acne in young populations, with rigorous study designs and consideration of previous contraceptive use.
Intrauterine devices: an update

Julia Hardeman,Barry D Weiss

2014-03-15

Abstract:Three intrauterine devices (IUDs) are available in the United States: the copper T 380A and two levonorgestrel-releasing IUDs, one that releases 20 mcg of levonorgestrel per 24 hours, and one that releases 14 mcg per 24 hours. All are safe and effective methods of contraception that work predominantly by prefertilization mechanisms. The copper T 380A IUD may be placed in nonpregnant women at any time in the menstrual cycle. The prescribing information for the 20- and 14-mcg levonorgestrel-releasing IUDs advises that insertion occur during the first seven days of menses. Insertion immediately after vaginal or cesarean delivery may be considered with the copper T 380A and the 20-mcg levonorgestrel-releasing IUDs; however, expulsion rates are higher than with delayed postpartum insertion. The prescribing information for both levonorgestrel-releasing IUDs advises a waiting period of six weeks postpartum or following second-trimester pregnancy loss. Current guidelines indicate that IUDs are acceptable for use in nulliparous women, in adolescents, and in women who are breastfeeding. They may also be used in women who have a history of sexually transmitted infection, although screening is recommended. IUDs should not be inserted for at least three months after resolution of a sexually transmitted infection. Neither antibiotic prophylaxis nor misoprostol use before IUD insertion is beneficial. If pregnancy occurs, the IUD should be removed if feasible. Possible side effects of levonorgestrel-releasing IUDs include headaches, nausea, hair loss, breast tenderness, depression, decreased libido, ovarian cysts, oligomenorrhea, and amenorrhea. The main side effect of the copper T 380A IUD is increased menstrual bleeding, which may continue even with long-term use.
Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women

Eliza Brull,Helymar C Machado,Luis Bahamondes,Cássia R T Juliato

DOI: https://doi.org/10.1080/13625187.2023.2215366

Abstract:Objective: To compare the continuation rates, expulsion, and other reasons for discontinuation of the hormonal intrauterine device with 52 mg of levonorgestrel (52 mg LNG-IUD) in adolescents and adult women. Methods: We conducted a retrospective cohort study that included 393 women in whom we placed a 52 mg LNG-IUD and followed up to 5 years. We created two retrospective cohorts, one with 131 adolescents (aged between 12 and 19 years) and the other with 262 women aged ≥20 years. Each adolescent was paired with two adult women who had the same parity and who had a 52 mg LNG-IUD inserted on the same day. We used the Mann-Whitney test to compare numerical variables in both groups, the Kaplan-Meier method, and the log-rank test to compare the continuation, expulsion and other reasons for IUD discontinuation of the two groups. Results: Age of the adolescents and adult women were mean ± SD 18.1 (±1.1) and 31 (±6.8) years, respectively (p = 0.015). Continuation rates by the fifth year of use were 55.6/100 women-years (W-Y) and 70.3/100 W-Y among adolescents and adult women (p = 0.106); and expulsion rates were 8.4/100 and 6.0/100 W-Y, respectively (p = 0.463). Adolescents had a lower continuation rate during 3 to 5 years of follow-up (p = 0.011) and a high rate of removals due to bleeding/pain (18.5 ± 5.7/100 W-Y vs 6.4/100 ± 2.1 W-Y, p = 0.039). Conclusion: Adolescents who used the 52 mg LNG-IUD showed a lower continuation rate 3-5 years after device placement than adult women. The expulsion rates were similar in both groups.
Continuation of the levonorgestrel-releasing intrauterine device among adolescents with endometriosis

Jessica Y. Shim,Carly E. Milliren,Amy D. DiVasta

DOI: https://doi.org/10.1016/j.jpag.2024.10.005

IF: 2.046

2024-10-29

Journal of Pediatric and Adolescent Gynecology

Abstract:Study Objective To estimate the 1-year continuation rate of the levonorgestrel-releasing intrauterine device (LNG-IUD) in adolescents with endometriosis, and the frequency at which additional systemic hormonal treatment (HT) is utilized. Methods A retrospective cohort study was performed of patients aged 12 – 21 years who underwent laparoscopy for endometriosis and LNG-IUD insertion at a single tertiary care institution between 2018 and 2021. Results We evaluated 224 adolescents (mean age=17.0, SD=1.8 years) who underwent LNG-IUD placement during laparoscopic evaluation for endometriosis. Stage I endometriosis was most common (84.4%), followed by stage II (13.0%). Of 221 with follow-up, 208 (94.1%) had HT added or continued post-surgery. The most common additional HT was norethindrone acetate (42.5%), followed by combined hormonal contraceptives (34.8%). The 1-year LNG-IUD continuation rate was 92.0%. There were 18 IUD removals (8%) by 1 year, and the median time to removal was 118 days (IQR=159; range 8-293). Use of additional HT was associated with a lower hazard of IUD removal within the first year of use (HR = 0.19, 95% CI: 0.06-0.56, p<0.001). Conclusion The majority of adolescents used the LNG-IUD with additional systemic HT for endometriosis management. While overall continuation was high, adolescents who were using LNG-IUD and HT were more likely to continue LNG-IUD than those who were not utilizing additional HT.

pediatrics,obstetrics & gynecology
Intrauterine contraceptive device training and outcomes for healthcare providers in developed countries: A systematic review

Menglu Ouyang,Ke Peng,Jessica R. Botfield,Kevin McGeechan

DOI: https://doi.org/10.1371/journal.pone.0219746

IF: 3.7

2019-07-15

PLoS ONE

Abstract:Intrauterine contraceptive devices (IUCD) are a safe and cost-effective contraceptive method for medically eligible women. Despite this, the utilisation rate for IUCDs is relatively low in many high-income countries, including Australia. Provision of education and training regarding IUCDs to healthcare providers, including nurses and midwives, is one approach to overcome some of the barriers that may prevent wider uptake of IUCDs. This study aims to explore the types and impact of IUCD insertion training for healthcare providers. A systematic review was undertaken in January 2017 to determine the effectiveness of IUCD training for healthcare providers in relation to provision of IUCDs to women. The databases MEDLINE, EMBASE, CINAHL, COCHRANE and SCOPUS were searched to identify studies from high-income countries relating to IUCD training for healthcare providers and relevant outcomes. A total of 30 studies were included in the review. IUCD training for healthcare providers contributed to increased knowledge and improved positive attitudes towards IUCDs, high rates of successful insertions, low complication rates, and increased provision of IUCDs. Successful insertions and low complication rates were similar across different healthcare provider types. No notable differences between provider types in terms of knowledge increase or insertion outcomes were observed. Different training programs for healthcare providers were found to be effective in improving knowledge and successful provision of IUCDs. Increasing the number of healthcare providers skilled in IUCD insertions in high-income countries, including nurses and midwives, will enhance access to this method of contraception and allow women greater contraceptive choice.

multidisciplinary sciences
Effect of sex steroids on bone collagen synthesis in vitro

E. Canalis,L. Raisz

DOI: https://doi.org/10.1007/BF02010758

1978-05-26

Calcified Tissue Research

Abstract:
70. Intrauterine Device Experiences in Gender Diverse Adolescents and Young Adults: A Multisite Study

Liz Abernathey,Morgan Ryan,Sarah Pitts,Amy DiVasta,Kym Ahrens,Sofya Maslyanskaya,Carly Milliren,Michelle Escovedo,Sarah Golub

DOI: https://doi.org/10.1016/j.jpag.2024.01.077

IF: 2.046

2024-04-04

Journal of Pediatric and Adolescent Gynecology

Abstract:Background To our knowledge, no studies have explored the intrauterine device (IUD) experience of gender diverse (GD) adolescents and young adults (AYA) who are and are not receiving gender-affirming testosterone therapy. We describe demographic characteristics, procedural outcomes, and continuation rates of these two groups of AYA seeking IUDs, and compare this experience to their cisgender peers. Methods This retrospective cohort study included AYA age 13-26 years seeking an IUD from 1/1/2020 to 12/31/2022 at 4 Adolescent Medicine clinics. GD was defined as a gender identity other than female and/or reporting transgender/gender dysphoria at the time of insertion. Descriptive statistics characterized the patient populations. Cochran-Mantel-Haenzel tests compared measures between groups. Kaplan-Meier and Cox proportional-hazard modeling assessed continuation rates. IRB approval was obtained at each site. Results Of 807 attempted IUD insertions, 744 (92%) were in cisgender and 63 (7.8%) in GD individuals, of whom 20 (32%) were on gender-affirming testosterone therapy at the time of insertion. There was no significant difference by IUD indication (p=0.90) between the 3 groups, with the majority seeking menstrual management alone or in combination with contraception; few desired contraception only. IUD insertion was successful in 672/744 (90%) cisgender AYA compared to 16/20 (80%) GD individuals on testosterone and 40/43 (93%) GD individuals not on testosterone. Procedural success did not differ between cisgender and GD individuals, regardless of testosterone use (p=0.10). No GD patients on testosterone required cervical dilation during insertion, while 3 (7%) GD patients not on testosterone and 65 (8.7%) cisgender patients required dilation. Unsuccessful insertions were more likely to have required dilation (43.6% of unsuccessful insertions versus 6.3% of completed insertions, p< 0.01). The one-year IUD continuation rate did not differ between groups: cisgender 87%, GD on testosterone 78%, and GD not on testosterone 93% (p=0.10). However, the three-year IUD continuation rate differed significantly between cisgender (81%), GD on testosterone (78%), and GD not on testosterone (87%) (p< 0.005). Conclusions Compared to cisgender peers, GD AYA experienced similarly high rates of successful IUD insertion, regardless of whether participants were on testosterone. While one-year continuation rates were high, and did not differ between groups, GD AYA on testosterone had a lower three-year continuation rate compared to the other groups.

pediatrics,obstetrics & gynecology
Menstrual suppression to decrease intrauterine device expulsion in adolescents with inherited bleeding disorders

Peter H. Cygan,Kelly M. Kons,Megan H. Fiorillo,Tonya S. Wright

DOI: https://doi.org/10.1002/ijgo.16063

2024-11-28

International Journal of Gynecology & Obstetrics

Abstract:Synopsis Intrauterine device efficacy in adolescents with heavy menstrual bleeding and bleeding disorders is impacted by expulsion within 30 days of insertion. Menstrual suppression may reduce this risk.

obstetrics & gynecology
Acoustic signal recognition with a photorefractive time-delay neural network.

G. Zhou,D. Z. Anderson

DOI: https://doi.org/10.1364/OL.19.000655

IF: 3.6

1994-05-01

Optics Letters

Abstract:We present a photorefractive processor for audio-acoustic signal recognition based on the time-delay neural network model of Hopfield and Tank [in Neural Models of Plasticity, J. H. Byrne, ed. (Academic, New York, 1989), p. 363-377]. We demonstrate the recognition of three words by programming the interconnection weights of the time-delay network.
Menstrual management in developmentally delayed adolescent females

Irene Chuah,Alexandra McRae,Kim Matthews,Ann M. Maguire,Katharine Steinbeck

DOI: https://doi.org/10.1111/ajo.12595

2017-03-15

Australian and New Zealand Journal of Obstetrics and Gynaecology

Abstract:BACKGROUND: Requests for assistance in menstrual management and menstrual suppression are a common, emotive and sometimes controversial aspect of adolescent disability care.AIMS: To review the uptake and outcomes of menstrual suppression among adolescent patients with developmental delay.METHODS: A retrospective review of the medical records of adolescent females with intellectual disability referred for menstrual management to the Paediatric and Adolescent Gynaecology Clinic, Children's Hospital at Westmead, Sydney, for the three-year period between January 1, 2010 and January 1, 2013.RESULTS: Eighty adolescent patients with developmental delay were identified. A third (n = 28) of the patients were pre-menarcheal at first review with parent/caregivers seeking anticipatory advice. Of the post-menarcheal patients, the median age of menarche was 12 years (range 10-15 years). First and second line interventions were documented as were reasons for change where applicable. The combined oral contraceptive pill (COCP) was the most frequently used therapy (67%), and 19 patients in total had a levonorgestrel releasing intrauterine system (LNG-IUS) inserted (31%). Our study population differs from similar previously published groups in the marked absence of the use of depot medroxyprogesterone acetate or the subdermal etonogestrel releasing device.CONCLUSION: As a paediatrician, it is important to address menstrual management issues and allay caregiver concerns with appropriate advice. Our study supports the use of the COCP as sound first line management in achieving menstrual suppression. The LNG-IUS appears to be a favourable second line option. Further investigation into longer-term outcomes and potential complications of device insertion is recommended.

obstetrics & gynecology
Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study

Reni Soon,Katie McGuire,Jennifer Salcedo,Bliss Kaneshiro

Abstract:This pilot study assessed the feasibility of conducting a larger randomized controlled trial comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG IUD) at six months postpartum when it is inserted immediately after vaginal delivery (within 10 minutes after placental expulsion) compared to insertion four to six weeks postpartum. Pregnant adolescents (14 to 19 years) who desired a LNG IUD for postpartum contraception were randomized to insertion of the LNG IUD either within 10 minutes of delivery of the placenta or at 4-6 weeks postpartum. Study follow-up visits were conducted at 4-6 weeks postpartum, 10 weeks postpartum, and 6 months postpartum. From November 2013 to June 2015, eleven adolescents were randomized - six participants to the immediate postpartum LNG IUD insertion group, and five to the delayed insertion group. All six women in the immediate insertion group had successful immediate postpartum insertion; two of five women in the delayed insertion group had an IUD inserted. At six months postpartum, four of six women in the immediate insertion group had a LNG IUD in place; of the five women in the delayed group, three did not have a LNG IUD in place and two were pregnant. The study was discontinued after 19 months because of suboptimal enrollment. Though insertion of a LNG IUD immediately after delivery is an appropriate option for some adolescents, a larger prospective study comparing immediate to delayed LNG IUD insertion is unlikely to be feasible at our institution.
Noble lessons from a kidney donor.

A. Al-Khader

2004-07-01

Saudi Journal of Kidney Diseases and Transplantation

Abstract:
Intrauterine Device Complications and Their Management

Melissa G. Myo,Brian T. Nguyen

DOI: https://doi.org/10.1007/s13669-023-00357-8

2023-04-27

Current Obstetrics and Gynecology Reports

Abstract:Abstract Purpose of Review Individuals are using intrauterine devices (IUDs) increasingly more frequently not only for contraception and emergency contraception, but also, in the case of hormonal IUDs, for the management of heavy menstrual bleeding and endometrial hyperplasia. While IUD complications are rare, their increasing prevalence is inevitably linked to more patients requiring specialized care for these complications. This review summarizes the most common complications, inclusive of perforation, expulsion, concurrent pregnancy, and difficult IUD removal, as well as their management strategies. Recent Findings The two most recent, large-scale, multi-site cohort studies examining IUD complications were conducted in Europe (European Active Surveillance Study for Intrauterine Devices (EURAS-IUD)) and the USA (Association of Perforation and Expulsion of Intrauterine Devices (APEX-IUD)), confirming the rarity of perforations, occurring in less than 0.5% of individuals over 5 years of follow-up and primarily at the time of or soon after insertion. These studies both confirmed the independent and increased risk of perforation among individuals receiving an IUD in the postpartum state, as well as among breastfeeding individuals. In the APEX-IUD study, the risk of perforation was noted to be elevated even up to 52 weeks postpartum, even when controlling for breastfeeding status. The same study also noted that 10.7% of individuals receiving IUDs within 3 days postpartum expelled their IUDs; while this proportion was significantly elevated compared to those waiting several weeks to receive their IUD, it is remarkably lower than rates seen in previous studies of immediate postpartum IUD insertion. Breastfeeding was protective against IUD expulsion. Additional studies note the incidence of IUD fragmentation and possible differences for rates of fragmentation by device type. Summary IUD complications are generally rare but can become serious or burdensome for patients if their reproductive healthcare providers are not aware of the possible risks and presentation. Understanding the potential for IUDs to perforate the uterus, be expelled, fail to prevent pregnancy, or be difficult to remove, along with the various risk factors linked to these complications, can help providers improve their counseling and take appropriate precautions with IUD insertion to better avoid them, as well as manage them when they inevitably occur.

English Else
Exploring Adolescent Contraceptive Counseling: A Hypothetical Daughter Scenario

Carmen Traseira Pedraz,Catherine Wong,Nirupama DeSilva,Megan Gribbons,Katelyn K Jetelina,Jasmin A Tiro,Jenny KR Francis

DOI: https://doi.org/10.1016/j.pec.2024.108486

IF: 3.467

2024-10-30

Patient Education and Counseling

Abstract:Objectives We aimed to describe contraceptive methods used by clinicians who counsel adolescents to create an aggregate perspective which could be shared with patients. We also explored which method clinicians would recommend to a hypothetical daughter to identify associations between clinicians who had used long-acting reversible contraception (LARC) and potential recommendations. Methods An online survey was sent to pediatric and adolescent gynecology academic societies and fellowship/division directors to share with their clinicians. Frequency and percentage of self-reported personal/partner contraceptive method ever use was calculated. Bivariate tests evaluated the relationship between personal LARC use and contraception recommendations. Results Across 669 clinicians, 46% reported personal/partner LARC use, and 77% recommended LARC to a hypothetical daughter. LARC users were more likely to recommend LARC for a hypothetical daughter (89% LARC users recommend it versus 66% non-LARC users, p<0.01). Conclusion Results can support shared decision-making counseling discussions. When families ask, "what do you use" or "what would you start for your daughter," clinicians might consider sharing this aggregate perspective. Practice Implications In this study, clinicians who personally use LARC were more likely to recommend LARC for a hypothetical daughter. Clinicians can share this aggregate perspective to reduce personal bias during contraceptive counselling.

public, environmental & occupational health,social sciences, interdisciplinary

Renal functional response to vasopressor agents in shock.

Intrauterine device use is safe among nulligravidas and adolescent girls

188. National Practices and Attitudes Surrounding Intrauterine Devices and Contraceptive Implant Procedures For Adolescents in the Inpatient Setting

64. Immediate postpartum IUD use among adolescents in the United States: Update from National Inpatient Sample

Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting

Multi Objective Optimization of Cloud Computing Services for Consumers

[An update in intrauterine contraception]

The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women

Intrauterine devices: an update

Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women

Continuation of the levonorgestrel-releasing intrauterine device among adolescents with endometriosis

Intrauterine contraceptive device training and outcomes for healthcare providers in developed countries: A systematic review

Effect of sex steroids on bone collagen synthesis in vitro

70. Intrauterine Device Experiences in Gender Diverse Adolescents and Young Adults: A Multisite Study

Menstrual suppression to decrease intrauterine device expulsion in adolescents with inherited bleeding disorders

Acoustic signal recognition with a photorefractive time-delay neural network.

Menstrual management in developmentally delayed adolescent females

Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study

Noble lessons from a kidney donor.

Intrauterine Device Complications and Their Management

Exploring Adolescent Contraceptive Counseling: A Hypothetical Daughter Scenario